Lineagen provides genetic testing, genetic counseling, and developmental screening services to support diagnosis of autism spectrum disorder and other developmental delays
Lineagen provides genetic testing, genetic counseling, and developmental screening services to support diagnosis of autism spectrum disorder and other developmental delays. Its programs also address conditions including multiple sclerosis and COPD. Its offerings include chromosomal microarray, whole-exome sequencing, Fragile X testing, and genome-wide structural variant assessment; the company was acquired by Bionano Genomics in 2020.
The top three firms on F4's Biotech & Life Sciences investor list.